Idaho doctor sentenced to prison for distributing drugs

Crime Watch

Share This

The following is a news release from the U.S. Attorney’s Office for the District of Idaho.

COEUR D’ALENE — Dr. Rafael Beier, 63, of Kingston, was sentenced Wednesday to 192 months in federal prison followed by ten years of supervised release for unlawfully distributing oxycodone and hydrocodone, U.S. Attorney Bart M. Davis announced. Senior U.S. District Judge Edward J. Lodge also ordered Dr. Beier to pay a $63,000 fine and to forfeit proceeds of $732,800.

In May 2016, a north Idaho jury found Dr. Beier guilty of conspiring to distribute oxycodone and hydrocodone and 61 separate counts of distributing a controlled substance. It is unlawful for a doctor to distribute controlled substances outside the usual course of their professional practice and not for a legitimate medical purpose.

Evidence at trial showed that between 2012 and May 2014, Dr. Beier sold prescriptions for highly addictive drugs like oxycodone, Adderall and hydrocodone in exchange for cash at locations such as bars, parking lots, stores, as well as his office. The jury heard evidence that Dr. Beier created false medical charts to explain the illegal drug sales.

The jury also saw the prescriptions written by Dr. Beier, a video of Dr. Beier discussing his drug sales with a witness, and an audio recording of a government informant buying a prescription from Dr. Beier in a bathroom stall. Witnesses included co-conspirators who sold pills for Beier, non-patients whose names were used on prescriptions and a number of people who bought prescriptions from Dr. Beier. Several witnesses testified about the substantial negative effect that opioid addiction had on their lives.

At the sentencing hearing, Judge Lodge stated, “Dr. Beier let greed, sexual satisfaction and the power of a prescription pad cloud his judgment.”

The case was investigated by Federal Bureau of Investigation (FBI), Drug Enforcement Administration (DEA), and North Idaho Violent Crimes Task Force (NIVCTF).

Respond to this story